Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer

Valesca P. Retel, Manuela A. Joore, Michael Knauer, Sabine C. Linn, Michael Hauptmann, Wim H. van Harten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1382-1391
JournalEuropean Journal of Cancer
Volume46
Issue number8
DOIs
Publication statusPublished - May 2010

Keywords

  • Breast cancer
  • Cost-effectiveness
  • Gene expression profiling
  • 70-Gene MammaPrint (R) signature

Cite this